|Day's Range||38.48 - 39.25|
|52 Week Range||31.07 - 47.95|
|PE Ratio (TTM)||17.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Merck, Novartis, Novo Nordisk, Regeneron, and Sanofi await big FDA decisions in May.
Danish pharmaceutical giant Novo Nordisk is being accused of engaging in a "white coat marketing...
Novo Nordisk A/S has agreed to settle a U.S. probe of its marketing of diabetes drugs that allegedly included disguising salespeople as medical educators and paying kickbacks to persuade doctors to prescribe ...